CC1(C)OCC2OC3([C@@H]4OC(C)(C)O[C@H]4CO)OC(C)(C)OC3C2O1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?